Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.67 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.60 |
| ▸ | GAA | P10253 | 2/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | NPC1 | O15118 | 1/20 | 0.56 |
| ▸ | HPGD | P15428 | 1/20 | 0.56 |
| ▸ | RAB9A | P51151 | 1/20 | 0.56 |
| ▸ | PKM | P14618 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | RECQL | P46063 | 1/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13917758 | 0.95 | ALDH1A1 (0.62) | ALDH1A1L3MBTL1GAAKMT2ASMN1; SMN2 | |
| SCHEMBL7261912 | 0.88 | ALDH1A1 (0.64) | ALDH1A1L3MBTL1GAAKMT2ASMN1; SMN2 | |
| SCHEMBL6506619 | 0.88 | ALDH1A1 (0.64) | ALDH1A1L3MBTL1GAAKMT2ASMN1; SMN2 | |
| SCHEMBL25305775 | 0.87 | L3MBTL1 (0.60) | ALDH1A1L3MBTL1GAAKMT2ASMN1; SMN2 | |
| SCHEMBL570839 | 0.87 | ALDH1A1 (0.73) | ALDH1A1L3MBTL1GAAKMT2ASMN1; SMN2 | |
| SCHEMBL7345656 | 0.86 | ALDH1A1 (0.62) | ALDH1A1L3MBTL1GAASMN1; SMN2KDM4E | |
| SCHEMBL28849841 | 0.86 | ALDH1A1 (0.62) | ALDH1A1L3MBTL1GAAKMT2ASMN1; SMN2 | |
| SCHEMBL20743530 | 0.84 | ALDH1A1 (0.60) | ALDH1A1L3MBTL1GAASMN1; SMN2KDM4E | |
| SCHEMBL22492367 | 0.84 | ALDH1A1 (0.60) | ALDH1A1GAAKMT2ASMN1; SMN2KDM4E | |
| SCHEMBL8285177 | 0.84 | MEP1B (0.62) | ALDH1A1GAAKMT2ASMN1; SMN2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3835300-B1 | 1,7-NAPHTHYRIDINE DERIVATIVE AND PREPARATION METHOD AND USE THEREFOR | CSPC ZHONGQI PHARMACEUTICAL TECH SHIJIAZHUANG CO LTD (CN) | 2025-02-19 | — | — | EP | disclosed |
| US-11981669-B2 | 1,7-naphthyridine derivative and preparation method and use therefor | CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD (CN) | 2024-05-14 | — | — | US | disclosed |
| CN-116874395-A | Visible light-promoted amino acid alpha-position alkylation modification method | 华中科技大学 | 2023-10-13 | — | — | CN | disclosed |
| CN-112689635-B | 1, 7-naphthyridine derivative and preparation method and application thereof | 石药集团中奇制药技术(石家庄)有限公司 | 2023-08-04 | — | — | CN | disclosed |
| CN-111116446-B | Synthetic process method of 3-substituted-1H-pyrrole | 成都师范学院 | 2023-07-14 | — | — | CN | disclosed |
| CN-113710669-A | Fused bicyclic heterocyclic derivatives as pesticides | 拜耳公司 | 2021-11-26 | — | — | CN | disclosed |
| US-20210332043-A1 | 1,7-NAPHTHYRIDINE DERIVATIVE AND PREPARATION METHOD AND USE THEREFOR | CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD (CN) | 2021-10-28 | — | — | US | disclosed |
| EP-3835300-A1 | 1,7-NAPHTHYRIDINE DERIVATIVE AND PREPARATION METHOD AND USE THEREFOR | CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. (CN) | 2021-06-16 | — | — | EP | disclosed |
| CN-112689635-A | 1, 7-naphthyridine derivative and preparation method and application thereof | 石药集团中奇制药技术(石家庄)有限公司 | 2021-04-20 | — | — | CN | disclosed |
| CN-111116446-A | Synthetic process method of 3-substituted-1H-pyrrole | 成都师范学院 | 2020-05-08 | — | — | CN | disclosed |
| US-20050143443-A1 | Pyrrole and pyrazole DAAO inhibitors | SEPRACOR INC. (US) | 2005-06-30 | — | — | US | disclosed |
| US-20040180910-A1 | Heterocycle carboxamides as antiviral agents | SCHNUTE MARK E (US) | 2004-09-16 | — | — | US | disclosed |
| US-6730682-B2 | HERPES VIRUS | PHARMACIA & UPJOHN COMPANY | 2004-05-04 | — | — | US | disclosed |
| EP-1363907-A2 | HETEROCYCLE CARBOXAMIDES AS ANTIVIRAL AGENTS | PHARMACIA & UPJOHN COMPANY (US) | 2003-11-26 | — | — | EP | disclosed |
| US-20020019397-A1 | Heterocycle carboxamides as antiviral agents | PHARMACIA & UPJOHN COMPANY | 2002-02-14 | — | — | US | disclosed |
| WO-2002004443-A2 | HETEROCYCLE CARBOXAMIDES AS ANTIVIRAL AGENTS | PHARMACIA & UPJOHN COMPANY (US) | 2002-01-17 | — | — | WO | disclosed |
| CN-1044237-C | 4,1-benzoxazep in derivatives and their use | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1999-07-21 | — | — | CN | disclosed |
| CN-1083481-A | 4,1-Benzoxazepine derivatives and its purposes | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1994-03-09 | — | — | CN | disclosed |
| US-4421693-A | INSECTICIDES, MITICIDES OR NEMATOCIDES | OTSUKA CHEMICAL CO., LTD. (JP) | 1983-12-20 | — | — | US | disclosed |
| US-4413005-A | 2,3-DIHYDRO-2,2-DIMETHYLBENZOFURAN-7-YL DERIVATIVES | OTSUKA KAGAKU YAKUHIN KABUSHIKI KAISHA (JP) | 1983-11-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210332043-A1 | 1,7-NAPHTHYRIDINE DERIVATIVE AND PREPARATION METHOD AND USE THEREFOR | HIF1A, HIF1AN, P4HA1 | ALDH1A1 922/4885L3MBTL1 4602/4885GAA 1081/4885 |
| US-20050143443-A1 | Pyrrole and pyrazole DAAO inhibitors | DDO, DAO, SRR | ALDH1A1 3634/4885L3MBTL1 398/4885GAA 2344/4885 |
| US-20040180910-A1 | Heterocycle carboxamides as antiviral agents | ZC3HAV1, ZC3HAV1L, HDAC1 | ALDH1A1 779/4885L3MBTL1 4225/4885GAA 1182/4885 |
| US-20020019397-A1 | Heterocycle carboxamides as antiviral agents | ZC3HAV1, ZC3HAV1L, HDAC1 | ALDH1A1 779/4885L3MBTL1 4225/4885GAA 1182/4885 |
| US-11981669-B2 | 1,7-naphthyridine derivative and preparation method and use therefor | HIF1A, HIF1AN, P4HA1 | ALDH1A1 922/4885L3MBTL1 4602/4885GAA 1081/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.